Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan;20(1):45-53.
doi: 10.3201/eid2001.130906.

Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast

Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast

David R Boulware et al. Emerg Infect Dis. 2014 Jan.

Abstract

Cryptococcal meningitis is common in sub-Saharan Africa. Given the need for data for a rapid, point-of-care cryptococcal antigen (CRAG) lateral flow immunochromatographic assay (LFA), we assessed diagnostic performance of cerebrospinal fluid (CSF) culture, CRAG latex agglutination, India ink microscopy, and CRAG LFA for 832 HIV-infected persons with suspected meningitis during 2006-2009 (n = 299) in Uganda and during 2010-2012 (n = 533) in Uganda and South Africa. CRAG LFA had the best performance (sensitivity 99.3%, specificity 99.1%). Culture sensitivity was dependent on CSF volume (82.4% for 10 μL, 94.2% for 100 μL). CRAG latex agglutination test sensitivity (97.0%-97.8%) and specificity (85.9%-100%) varied between manufacturers. India ink microscopy was 86% sensitive. Laser thermal contrast had 92% accuracy (R = 0.91, p<0.001) in quantifying CRAG titers from 1 LFA strip to within <1.5 dilutions of actual CRAG titers. CRAG LFA is a major advance for meningitis diagnostics in resource-limited settings.

Keywords: Cryptococcus spp.; HIV; India ink microscopy; South Africa; Uganda; cerebrospinal fluid; cryptococcal antigen; cryptococcal antigen latex agglutination; cryptococcal meningitis; culture; diagnostic techniques; fungi; laser thermal contrast measurement; lateral flow immunochromatographic assay; point-of-care systems; sensitivity; specificity; validation studies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Five steps of the cryptococcal antigen lateral flow assay.
Figure 2
Figure 2
Venn diagram of distribution of 393 cryptococcal meningitis cases tested by 4 diagnostic assays, Uganda and South Africa. CSF, cerebrospinal fluid; CRAG LFA, cryptococcal antigen lateral immunochromatographic flow assay; India ink, India ink microscopy of 1 mL of concentrated CSF specimen. Numbers at the bottom right indicate 2 scenarios in which the Venn diagram does not overlap visually.
Figure 3
Figure 3
A) Prediction of cryptococcal antigen titer based on laser thermal contrast measurement and concept of lateral flow immunochromatographic assay (LFA) thermal contrast measurement in which a laser irradiates the test line in the LFA (19). The test line is formed by gold–monoclonal antibody–antigen sandwich complex with a monoclonal antibody affixed at the test line. When irradiated by a green laser (532 nm), any gold present absorbs light from the laser and generates heat in direct proportion to the amount of gold (and thereby antigen) present at the test line. This temperature change can be measured by using an infrared camera. B) Association of measured semiquantitative LFA cryptococcal antigen (CRAG) titer starting at a 1:250 dilution by the predicted CRAG titer based on thermal contrast measurement. Measurements on the negative portion of the x-axis are beyond the visual range when specimens were diluted 1:250, yet still detectable by thermal contrast. The Pearson correlation coefficient was r = 0.91 (p<0.001, R2 = 0.84) among 115 positive specimens quantified. A total of 58 LFA CRAG–negative specimens established background levels of heat radiation.

References

    1. Jarvis JN, Meintjes G, Williams A, Brown Y, Crede T, Harrison TS. Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases. BMC Infect Dis. 2010;10:67 .10.1186/1471-2334-10-67 - DOI - PMC - PubMed
    1. Hakim JG, Gangaidzo IT, Heyderman RS, Mielke J, Mushangi E, Taziwa A, et al. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 2000;14:1401–7 .10.1097/00002030-200007070-00013 - DOI - PubMed
    1. Cohen DB, Zijlstra EE, Mukaka M, Reiss M, Kamphambale S, Scholing M, et al. Diagnosis of cryptococcal and tuberculous meningitis in a resource-limited African setting. Trop Med Int Health. 2010;15:910–7 .10.1111/j.1365-3156.2010.02565.x - DOI - PubMed
    1. Durski KN, Kuntz KM, Yasukawa K, Virnig BA, Meya DB, Boulware DR. Cost-effective diagnostic checklists for meningitis in resource-limited settings. J Acquir Immune Defic Syndr. 2013;63:e101–8 .10.1097/QAI.0b013e31828e1e56 - DOI - PMC - PubMed
    1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23:525–30 .10.1097/QAD.0b013e328322ffac - DOI - PubMed

Publication types

MeSH terms

Substances